129 related articles for article (PubMed ID: 19875954)
1. Is the expression pattern of BD ProExC the same as Ki-67? A comparative analysis in cervical biopsies.
Walts AE; Bose S
Appl Immunohistochem Mol Morphol; 2010 May; 18(3):262-7. PubMed ID: 19875954
[TBL] [Abstract][Full Text] [Related]
2. [Expression of ProEXC, p16 and Ki-67 in cervical intraepithelial lesion by immunohistochemistry: diagnostic and clinical significance].
Yang QC; Liu HB; Zhu Y; Zhang XJ; Shen Y; Ji XH
Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):405-7. PubMed ID: 22932410
[No Abstract] [Full Text] [Related]
3. Longitudinal clinical evaluation of a novel antibody cocktail for detection of high-grade squamous intraepithelial lesions on cervical cytology specimens.
Tambouret RH; Misdraji J; Wilbur DC
Arch Pathol Lab Med; 2008 Jun; 132(6):918-25. PubMed ID: 18517273
[TBL] [Abstract][Full Text] [Related]
4. BD ProEx C: a sensitive and specific marker of HPV-associated squamous lesions of the cervix.
Badr RE; Walts AE; Chung F; Bose S
Am J Surg Pathol; 2008 Jun; 32(6):899-906. PubMed ID: 18425044
[TBL] [Abstract][Full Text] [Related]
5. p16, Ki-67, and BD ProExC immunostaining: a practical approach for diagnosis of cervical intraepithelial neoplasia.
Walts AE; Bose S
Hum Pathol; 2009 Jul; 40(7):957-64. PubMed ID: 19269017
[TBL] [Abstract][Full Text] [Related]
6. Histology of cervical intraepithelial neoplasia and the role of biomarkers.
Martin CM; O'Leary JJ
Best Pract Res Clin Obstet Gynaecol; 2011 Oct; 25(5):605-15. PubMed ID: 21636328
[TBL] [Abstract][Full Text] [Related]
7. High-content imaging in cervical cancer screening.
Micalessi MI; Boulet G; Pintelon I; Verstraelen P; Nauwelaers F; Ryser M; Bogers J
J Biomol Screen; 2013 Jan; 18(1):135-42. PubMed ID: 22972847
[TBL] [Abstract][Full Text] [Related]
8. Ki-67 quantitative evaluation as a marker of cervical intraepithelial neoplasia and human papillomavirus infection.
Mimica M; Tomić S; Kardum G; Hofman ID; Kaliterna V; Pejković L
Int J Gynecol Cancer; 2010 Jan; 20(1):116-9. PubMed ID: 20130511
[TBL] [Abstract][Full Text] [Related]
9. Role of ProExC: a novel immunoperoxidase marker in the evaluation of dysplastic squamous and glandular lesions in cervical specimens.
Sanati S; Huettner P; Ylagan LR
Int J Gynecol Pathol; 2010 Jan; 29(1):79-87. PubMed ID: 19952938
[TBL] [Abstract][Full Text] [Related]
10. Dual immunostaining of cervical cytology specimens with atypical squamous cells for p16/Ki-67 does not exclude the existence of a high-grade squamous intraepithelial lesion.
Koo YJ; Hahn HS; Lee IH; Lim KT; Lee KH; Kim HS; Kim TJ; Chun YK; Kim HS; Hong SR
Virchows Arch; 2013 Nov; 463(5):689-96. PubMed ID: 24081504
[TBL] [Abstract][Full Text] [Related]
11. Immunocytochemical study of TOP2A and Ki-67 in cervical smears from women under routine gynecological care.
Peres AL; Paz E Silva KM; de Araújo RF; de Lima Filho JL; de Melo Júnior MR; Martins DB; de Pontes Filho NT
J Biomed Sci; 2016 May; 23(1):42. PubMed ID: 27175798
[TBL] [Abstract][Full Text] [Related]
12. CINtec® PLUS dual immunostain: a triage tool for cervical pap smears with atypical squamous cells of undetermined significance and low grade squamous intraepithelial lesion.
Loghavi S; Walts AE; Bose S
Diagn Cytopathol; 2013 Jul; 41(7):582-7. PubMed ID: 22833355
[TBL] [Abstract][Full Text] [Related]
13. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies.
Dray M; Russell P; Dalrymple C; Wallman N; Angus G; Leong A; Carter J; Cheerala B
Pathology; 2005 Apr; 37(2):112-24. PubMed ID: 16028838
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of fully automated p16/Ki-67 dual staining in the triage of HPV-positive women in the Norwegian Cervical Cancer Screening Program.
Ovestad IT; Dalen I; Hansen E; Loge JL; Dybdahl BM; Dirdal MB; Moltu P; Berland JM
Cancer Cytopathol; 2017 Apr; 125(4):283-291. PubMed ID: 27918650
[TBL] [Abstract][Full Text] [Related]
15. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H].
Wu Y; Zhao J; Hu J; Wu XW; Zhu LR
Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):734-739. PubMed ID: 29179267
[No Abstract] [Full Text] [Related]
16. Efficacy of p16 and ProExC immunostaining in the detection of high-grade cervical intraepithelial neoplasia and cervical carcinoma.
Guo M; Baruch AC; Silva EG; Jan YJ; Lin E; Sneige N; Deavers MT
Am J Clin Pathol; 2011 Feb; 135(2):212-20. PubMed ID: 21228361
[TBL] [Abstract][Full Text] [Related]
17. Comparison of topoisomerase II alpha and MIB-1 expression in uterine cervical squamous lesions.
Gibbons D; Fogt F; Kasznica J; Holden J; Nikulasson S
Mod Pathol; 1997 May; 10(5):409-13. PubMed ID: 9160303
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of p16INK4a and Ki-67 proteins expression in cervical intraepithelial neoplasia and their correlation with HPV-HR infection].
Ungureanu C; Teleman S; Socolov D; Anton G; Mihailovici MS
Rev Med Chir Soc Med Nat Iasi; 2010; 114(3):823-8. PubMed ID: 21243810
[TBL] [Abstract][Full Text] [Related]
19. Utility of ProExC and IMP3 immunocytochemical staining in atypical glandular cells of undetermined significance in liquid-based cervical cytology.
Lastra RR; Ou JJ; Reilly ME; Lawrence WD; Baloch ZW; Brooks JS; Barroeta JE
Diagn Cytopathol; 2014 May; 42(5):375-9. PubMed ID: 23904388
[TBL] [Abstract][Full Text] [Related]
20. Effect of human papillomavirus on cell cycle-related proteins p16, Ki-67, Cyclin D1, p53, and ProEx C in precursor lesions of cervical carcinoma: a tissue microarray study.
Conesa-Zamora P; Doménech-Peris A; Orantes-Casado FJ; Ortiz-Reina S; Sahuquillo-Frías L; Acosta-Ortega J; García-Solano J; Pérez-Guillermo M
Am J Clin Pathol; 2009 Sep; 132(3):378-90. PubMed ID: 19687314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
